Cargando…

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings

SIMPLE SUMMARY: Prostate cancer (PCa) patient mortality rates remain high in patients with aggressive disease and the overtreatment of indolent tumors remains a major issue. Prostate-specific antigen (PSA), a standard PCa blood biomarker, is limited in its ability to differentiate disease subtypes,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gironda, Daniel J., Bergan, Raymond C., Alpaugh, R. Katherine, Danila, Daniel C., Chuang, Tuan L., Hurtado, Brenda Y., Ho, Thai, Adams, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378487/ https://www.ncbi.nlm.nih.gov/pubmed/37509385 http://dx.doi.org/10.3390/cancers15143725

Ejemplares similares

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time
por: Ali, Amama, et al.
Publicado: (2023)

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer
por: Kasabwala, Dimpal M., et al.
Publicado: (2022)

Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype
por: Green, Toni M., et al.
Publicado: (2015)

Aggressive Metastatic Chordoma in the Wrist
por: Abraham, Jasson, et al.
Publicado: (2014)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression
por: Voll, Eric A, et al.
Publicado: (2014)

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012)

Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
por: Inaba, Koji, et al.
Publicado: (2021)

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy
por: Gironda, Daniel J., et al.
Publicado: (2020)

Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan
por: Abunasser, Mahmoud, et al.
Publicado: (2023)

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
por: Fernandez, Sandra V., et al.
Publicado: (2020)

Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer
por: Vieira, Heidi M., et al.
Publicado: (2023)

The role and indications of aggressive locoregional therapy in metastatic inflammatory breast cancer
por: Yan, Yi, et al.
Publicado: (2016)

A Case of Leptomeningeal Carcinomatosis from Aggressive Metastatic Prostate Cancer
por: Carroll, Ryan David, et al.
Publicado: (2019)

Lung malignancy in prostate cancer: A report of both metastatic and primary lung lesions
por: Reinstatler, Lael, et al.
Publicado: (2017)

The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
por: Wang, Huogang, et al.
Publicado: (2021)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Metastatic Phenotype during Metastatic Latency in the Bone
por: Marsden, Carolyn G., et al.
Publicado: (2012)

CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Cutaneous presentation of metastatic pancreatic cancer
por: Abdelaziz, Mohammed, et al.
Publicado: (2022)

LDHA Desuccinylase Sirtuin 5 as A Novel Cancer Metastatic Stimulator in Aggressive Prostate Cancer
por: Kwon, Oh Kwang, et al.
Publicado: (2023)

Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype
por: Opinto, Giuseppina, et al.
Publicado: (2017)

Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review)
por: Liu, Bailong, et al.
Publicado: (2023)

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer
por: Alves, Carla L., et al.
Publicado: (2018)

Evolving Natural History of Metastatic Prostate Cancer
por: Nafissi, Nellie N, et al.
Publicado: (2020)

Metastatic and locally aggressive BCC: Current treatment options
por: Casey, Máire‐Caitlín, et al.
Publicado: (2021)

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?
por: Kolling, Stefan, et al.
Publicado: (2020)

The lingering mysteries of metastatic recurrence in breast cancer
por: Riggio, Alessandra I., et al.
Publicado: (2020)

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
por: Landers, K A, et al.
Publicado: (2008)

Cytoreductive surgery for men with metastatic prostate cancer
por: Katelaris, Nikolas, et al.
Publicado: (2016)

Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
por: Stenberg, Daniel, et al.
Publicado: (2021)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer
por: Riaz, Syeda Kiran, et al.
Publicado: (2018)

Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors
por: Li, Qing Kay, et al.
Publicado: (2021)

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
por: Das, Rajdeep, et al.
Publicado: (2021)

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
por: Rippaus, Nora, et al.
Publicado: (2016)

Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
por: Etzerodt, Anders, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_upn7em5jj4t3b3fckoqp7v9m19